FDA Seeks Accelerated Approval for Direct-to-Consumer Prescription Drug Website Disclosures

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking accelerated approval for disclosures on direct-to-consumer prescription drug websites.